Brief: Fate Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results And Business Updates
28/02/2023 22:18
Feb 28 (Reuters) - Fate Therapeutics Inc FATE.O :
* FATE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND BUSINESS UPDATES
* FATE THERAPEUTICS INC - ENDED 2022 WITH APPROXIMATELY $475
MILLION IN CASH, CASH EQUIVALENTS, AND RECEIVABLES
* FATE THERAPEUTICS INC - QTRLY NET LOSS PER COMMON SHARE,
BASIC
AND DILUTED $0.58
Source text for Eikon: ID:nGNX1Lm3cR
Further company coverage: FATE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fate Therapeutics
See all newsBrief: Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial Of FT819 For The Treatment Of Lupus Nephritis
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Q2 loss narrows as expenses fall, revenue rises
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview